Objective To investigate the therapeutic effect of finerenone combined with dapagliflozin on type 2 dia-betic nephropathy.Methods A total of 60 patients with type 2 diabetic nephropathy admitted to Donghai County People's Hospital from January 2022 to October 2023 were selected as the study objects and were divided into the control group and the study group by random number table method,with 30 cases in each group.The control group was treated with conventional therapy,and the study group was treated with finerenone combined with dapagliflozin.Compared the changes of blood glucose level and renal function indexes in the two groups,the incidence of adverse re-actions and the clinical therapeutic effect.Results The blood glucose level and renal function indexes of the study group after treatment were better than those of the control group,and the differences were significantly significant(all P<0.05).The incidence rate of adverse reactions during medication in the study group(6.67%)was lower than that of the control group(16.67%),and the difference was significantly significant(χ2=4.088,P<0.05).The treatment effec-tiveness rate of 96.67%in the study group was significantly higher than that of 80.00%in the control group,and the difference was significantly significant(χ2=2.623,P<0.05).Conclusion The combination of finerenone and dapa-gliflozin can provide better therapeutic effects for patients with type 2 diabetic nephropathy,both in terms of safety and alleviation of the disease.
Type 2 diabetic nephropathyFinerenoneDapagliflozin
NETL
NSTL
万方数据
